000 01576 a2200397 4500
005 20250518053756.0
264 0 _c20190828
008 201908s 0 0 eng d
022 _a1432-1335
024 7 _a10.1007/s00432-019-02993-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPak, Sahyun
245 0 0 _aDihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
_h[electronic resource]
260 _bJournal of cancer research and clinical oncology
_cSep 2019
300 _a2293-2301 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAndrogen Receptor Antagonists
_xpharmacology
650 0 4 _aCarcinoma, Renal Cell
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDihydrotestosterone
_xpharmacology
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aReceptors, Androgen
_xphysiology
650 0 4 _aReceptors, Glucocorticoid
_xphysiology
650 0 4 _aSTAT5 Transcription Factor
_xgenetics
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTumor Suppressor Proteins
_xgenetics
700 1 _aKim, Wansuk
700 1 _aKim, Yunlim
700 1 _aSong, Cheryn
700 1 _aAhn, Hanjong
773 0 _tJournal of cancer research and clinical oncology
_gvol. 145
_gno. 9
_gp. 2293-2301
856 4 0 _uhttps://doi.org/10.1007/s00432-019-02993-1
_zAvailable from publisher's website
999 _c29994787
_d29994787